Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $6 Million Public Offering of Avinger Inc. Common Stock
Press Release – New York, NY – August 6, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 15,789,474 shares of the common stock of Avinger Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), at a price of $0.38 per share. The offering was made pursuant to a registration statement on Form S-3 (No. 333-230124) which was previously filed with the Securities and Exchange Commission and declared effective on March 29, 2019.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin Ocasio, and Avital Perlman and associate Jacob Tabman.
- Sichenzia Ross Ference LLP Announces Over 80 Capital Markets Transactions Valued Over $2 Billion at the Closing of 2021 - January 13, 2022
- Sichenzia Ross Ference LLP Adds Two Key Additions to its Corporate and Securities Law Team - January 11, 2022
- Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $9.8 Million Underwritten Offering of BiondVax Pharmaceuticals Ltd. - December 30, 2021